• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RESONATE X4 CRT-D; IMPLANTABLE DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RESONATE X4 CRT-D; IMPLANTABLE DEFIBRILLATOR Back to Search Results
Model Number G447
Device Problems Failure to Convert Rhythm (1540); Under-Sensing (1661)
Patient Problem Ventricular Fibrillation (2130)
Event Date 02/28/2023
Event Type  Injury  
Event Description
It was reported, that the patient with this cardiac resynchronization therapy defibrillator (crt-d).Entered in an intrinsic ventricular tachycardia episode.The device appropriately delivered anti tachy pacing (atp) and shocks.However, they were unsuccessful.The rhythm accelerated into a ventricular fibrillation.Which was initially undersensed.Which made the first attempt to deliver a shock for the ventricular fibrillation to be aborted.Eventually, a second attempt was performed.And a shock was delivered by the device which ended the episode.Reprograming of the device and defibrillator threshold (dft) test were discussed.This device remains in service.No further adverse patient effects were reported.
 
Event Description
It was reported that the patient with this cardiac resynchronization therapy defibrillator (crt-d) entered in an intrinsic ventricular tachycardia episode.The device appropriately delivered anti tachy pacing (atp) and shocks, however they were unsuccessful.The rhythm accelerated into a ventricular fibrillation which was initially undersensed.Which made the first attempt to deliver a shock for the ventricular fibrillation to be aborted.Eventually, a second attempt was performed and a shock was delivered by the device which ended the episode.Reprograming of the device and defibrillator threshold (dft) test were discussed.This device remains in service.No further adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESONATE X4 CRT-D
Type of Device
IMPLANTABLE DEFIBRILLATOR
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key17043032
MDR Text Key316409408
Report Number2124215-2023-27905
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526589539
UDI-Public00802526589539
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010012/S436
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 06/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date06/15/2023
Device Model NumberG447
Device Catalogue NumberG447
Device Lot Number262691
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/12/2023
Initial Date FDA Received06/01/2023
Supplement Dates Manufacturer Received05/12/2023
Supplement Dates FDA Received06/02/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/28/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Life Threatening;
Patient Age59 YR
Patient SexMale
-
-